pretickt

State Street Health Care Select Sector SPDR ETF (XLV)

Tracks the Health Care Select Sector Index · 60 holdings · end-of-day data as of Nov 13, 2026

The whole sector on pretickt

State Street Health Care Select Sector SPDR ETF
XLV · $50.57B
$188.85+0.5%
Nov 13, 2026 · close
$170$180$190SepOctNov9:3016:003 months +11.7%Nov 13close
▲ Bullish readings 4
  • ConsensusBuy · 1,380
  • Trendbullish
  • MAs4 of 4
  • MACD0.12
Neutral
  • Earnings in68d
  • P/E32.9x
  • RSI67
  • Support-8.4%
  • Off 52w high-1.8%
  • Volume0.5x
  • Bollingerupper half
  • News
  • Price target at$192.48 +1.9%
  • 52w range$142–$192
  • ATR+1.8%
  • Off ATH-1.8%
▼ Bearish readings 0
None right now

Basket figures cover 100% of this fund. Updates with the 15-min delayed price; analysts and news are from the last close. Not a forecast or investment advice.

XLV holds 60 stocks; the largest is Eli Lilly LLY at 16.9%. Analysts' targets on the 100% of the fund we cover average +1.9%, which would put it at $192.48. pretickt does not say whether to buy or sell.

Why it moved

XLV rose 0.54%. Eli Lilly added 0.21 points, Johnson & Johnson 0.08.

Close of Nov 13, 2026

Pushed it up

Eli Lilly16.9%+1.3%+0.21HIMS Partners With Lilly to Offer FDA-Approved Weight-Loss Drugs
Johnson & Johnson10.1%+0.8%+0.084 Healthcare Dividend Stocks for Retirees. One Yields Over 4%
McKesson1.9%+2.4%+0.04McKesson: Slower FY2028 Revenue Growth Makes Today's Premium Less Attractive
Medtronic1.8%+1.9%+0.034 Healthcare Dividend Stocks for Retirees. One Yields Over 4%
Bristol-Myers Squibb1.9%+1.8%+0.034 Healthcare Dividend Stocks for Retirees. One Yields Over 4%

Pulled it down

Moderna1.2%-3.4%-0.04Moderna Issues Cost Outlook Amid Revenue Uncertainty, Stock Falls
Vertex2.0%-0.7%-0.01Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
IQVIA0.6%-2.2%-0.01IQVIA Stock Jumps 59% in 6 Months: Here's What You Should Know
Stryker1.6%-0.9%-0.01
Amgen3.7%-0.3%-0.01Dividend Champion, Contender, And Challenger Highlights: Week Of November 15

Weight, move and points of the fund's move. The move above is the fund's own price; the gap from its companies is the part we do not cover, and fees.

Analyst price target and consensus

Analysts' targets on its holdings, weighted as it holds them today, week by week over the last 12 months · last close $188.85 · as of Nov 13, 2026

— actual price● a week's target above it● below it┄ last close and today's targethover a dot to see its largest companies that week ·wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
⇔⇕$192TARGET$189TODAYNov 25Apr 26Sep 26Feb 27Jul 27Dec 27-13%-8%-7%-3%+1%

$192.48 +1.9%

What analysts' targets on 100% of the fund would put it at. The median holding reads +1.4%.

62% Buy of 1,380 ratings

34% Hold · 4% Sell. Each holding's counts, summed, on 100% of the fund.

P/E 32.9x

Weighted harmonic mean on 83% of the fund: companies with losses are left out.

Weighted by the fund. Price only, with no dividends or fees. Targets added up this way have run high: FactSet's for the S&P 500 ran 9.7% above the index on average over 20 years and 0.1% over 10 (FactSet, Sept. 2022).

Holdings

We cover 100% of this fund. Weights recomputed at the last close.

HoldingWeightDayUpsideConsensus
LLYEli Lilly and Company16.9%+1.3%-2.8%Buy
JNJJohnson & Johnson10.1%+0.8%-1.3%Buy
ABBVAbbVie Inc.7.6%+0.2%+4.0%Buy
UNHUnitedHealth Group Incorporated5.3%+0.6%+13.1%Buy
MRKMerck & Co., Inc.5.3%+0.6%+8.0%Buy
TMOThermo Fisher Scientific Inc.3.8%+0.1%+0.9%Buy
AMGNAmgen Inc.3.7%-0.3%-9.1%Hold
GILDGilead Sciences, Inc.3.0%+0.1%-1.7%Buy
ABTAbbott Laboratories2.7%+1.2%+11.8%Buy
PFEPfizer Inc.2.4%+0.2%+1.9%Hold
ISRGIntuitive Surgical, Inc.2.3%+0.8%+12.3%Buy
DHRDanaher Corporation2.1%+0.4%+4.5%Buy
VRTXVertex Pharmaceuticals Incorporated2.0%-0.7%+6.6%Buy
BMYBristol-Myers Squibb Company1.9%+1.8%+4.9%Hold
MCKMcKesson Corporation1.9%+2.4%-9.8%Buy
MDTMedtronic Plc1.8%+1.9%-3.7%Buy
CVSCVS Health Corp.1.7%-0.5%+23.4%Buy
SYKStryker Corporation1.6%-0.9%+18.1%Buy
REGNRegeneron Pharmaceuticals, Inc.1.4%+0.4%-6.5%Buy
ELVElevance Health Inc.1.4%0.0%+7.4%Buy
MRNAModerna, Inc.1.2%-3.4%-45.2%Hold
CICigna Corporation1.1%+0.2%+15.2%Buy
HCAHCA Healthcare, Inc.1.1%-0.3%-5.3%Buy
CORCencora, Inc.1.0%+3.0%+1.6%Buy
CAHCardinal Health, Inc.1.0%+1.1%+1.1%Buy

Is XLV a good buy?

By weight, XLV's holdings are strong on 60% of the questions about the business; weakest on advantage. Each reading rests on at least 84% of the fund.

Demand43% strong · 45% in between · 12% weak · on 100% of the fund
Advantage40% strong · 43% in between · 16% weak · on 84% of the fund
Economics60% strong · 29% in between · 11% weak · on 99% of the fund
Execution86% strong · 9% in between · 5% weak · on 100% of the fund
Fragility71% strong · 26% in between · 3% weak · on 100% of the fund
Price36% strong · 21% in between · 43% weak · on 100% of the fund

Shares of the weight with a reading on each question; a card our public checks contradict stays out. Fragility leaves out utilities and real estate: its score reads their normal debt as distress.

Fee
0.08% a year
Assets
$50.57B
Holdings
60
Top 10
61% of the fund
1 year
+25.7% (SPY +13.5%)
5 years
+53.1% (SPY +72.6%)
Dividend yield
1.4%

pretickt does not say whether to buy or sell.

Price and events

⇔⇕$145$159$173$187Nov 25Feb 26May 26Aug 26Nov 26Feb 27MMMMMMMDMMMMEMEMEEMMMMMMMMDMMMMEEMEMEMMMMMMMDMMMMEEMMEEEMMMMMMMDMMMEMMMEEMMMMMMMMMEEMEE

Last close $188.85 · +25.7% over 1y · E earnings · D dividend · S split · M market event

News of its largest holdings

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.

Questions about XLV

What does XLV hold?

XLV holds 60 stocks; the largest is Eli Lilly at 16.9%, then Johnson & Johnson at 10.1%. As of Nov 13, 2026.

What is the price target for XLV?

Analysts' targets on the 100% of the fund with at least 3 targets average +1.9%, which would put XLV at $192.48, as of Nov 13, 2026. Price only, with no dividends or fees.

Is XLV a good buy?

By weight, XLV's holdings are strong on 60% of the questions about the business; weakest on advantage. Each reading rests on at least 84% of the fund. pretickt does not say whether to buy or sell.

Why did XLV move?

XLV rose 0.54%. Eli Lilly added 0.21 points, Johnson & Johnson 0.08. As of Nov 13, 2026.

What is the expense ratio of XLV?

XLV charges 0.08% a year, as of Nov 13, 2026.